Zobrazeno 1 - 10
of 943
pro vyhledávání: '"S. Zent"'
Autor:
Farhad Ravandi, Robert J. Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sasha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Jeffrey Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae H. Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Philip A. Thompson, Xavier Troussard, Clive S. Zent, Thorsten Zenz, Pier Luigi Zinzani, Bernhard Wörmann, Kanti Rai, Michael Grever
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 12, Pp 1-7 (2022)
Abstract A significant body of literature has been generated related to the detection of measurable residual disease (MRD) at the time of achieving complete remission (CR) in patients with hairy cell leukemia (HCL). However, due to the indolent natur
Externí odkaz:
https://doaj.org/article/b522c851a9074f98bd78424982d9e633
Autor:
Saadia Sherazi, Susan Schleede, Scott McNitt, Carla Casulo, Jeremiah E. Moore, Eugene Storozynsky, Arpan Patel, Neelima Vidula, Mehmet K. Aktas, Clive S. Zent, Ilan Goldenberg
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 6 (2023)
Background There are limited data on risk of arrhythmias among patients with lymphoproliferative disorders. We designed this study to determine the risk of atrial and ventricular arrhythmia during treatment of lymphoma in a real‐world setting. Meth
Externí odkaz:
https://doaj.org/article/90fe15e8420a4bfab40bc8345039f481
Autor:
Jonathan J. Pinney, Sara K. Blick-Nitko, Andrea M. Baran, Derick R. Peterson, Hannah E. Whitehead, Raquel Izumi, Veerendra Munugalavadla, Karl R. Van DerMeid, Paul M. Barr, Clive S. Zent, Michael R. Elliott, Charles C. Chu
Publikováno v:
Haematologica, Vol 107, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/4bd1f29c68844e0bae492fc8f88bccbe
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 553-554 (2022)
Externí odkaz:
https://doaj.org/article/639003b1a27b4391947b2d91043bd3e4
Publikováno v:
Case Reports in Hematology, Vol 2021 (2021)
Acute eosinophilic leukemia (AEL) is a rare form of acute myeloid leukemia (AML) that requires prompt exclusion of reactive etiologies of eosinophilia and identification of an underlying acute myeloid neoplasm. Myeloid neoplasms with prominent eosino
Externí odkaz:
https://doaj.org/article/d93bfee01b3f4e35913535be554e6d9b
Autor:
Kriti Thapa, Myla Strawderman, Patrick M. Reagan, Paul M. Barr, Clive S. Zent, Jonathan W. Friedberg, Tina Faugh, Carla Casulo
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia.
Autor:
Simone C. Oostindie, Hilma J. van der Horst, Margaret A. Lindorfer, Erika M. Cook, Jillian C. Tupitza, Clive S. Zent, Richard Burack, Karl R. VanDerMeid, Kristin Strumane, Martine E. D. Chamuleau, Tuna Mutis, Rob N. de Jong, Janine Schuurman, Esther C. W. Breij, Frank J. Beurskens, Paul W. H. I. Parren, Ronald P. Taylor
Publikováno v:
Haematologica, Vol 104, Iss 9 (2019)
CD20 monoclonal antibody therapies have significantly improved the outlook for patients with B-cell malignancies. However, many patients acquire resistance, demonstrating the need for new and improved drugs. We previously demonstrated that the natura
Externí odkaz:
https://doaj.org/article/8951ab20ead14f0a871191432d4962ce
Autor:
Narendranath Epperla, Qiuhong Zhao, Mirela Anghelina, Jasmine Neal, James S. Blachly, Kerry A. Rogers, Gerard Lozanski, Christopher C. Oakes, Seema A. Bhat, Clive S. Zent, Versha Banerji, Michael Grever, Leslie A. Andritsos
Publikováno v:
American Journal of Hematology. 98
Autor:
Danielle S Wallace, Clive S Zent, Andrea M Baran, Patrick M Reagan, Carla Casulo, Geoffrey Rice, Jonathan W. Friedberg, Paul M Barr
Publikováno v:
Blood Advances.
BTK inhibitors are an effective therapy for previously untreated patients with CLL but require indefinite duration treatment that can result in cumulative toxicities. Novel combinations of agents that provide deep remissions could allow for fixed dur
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.